Z-Alpha Therapeutics Revenue
Biotechnology Research • • 11-20 Employees
$
Z-Alpha Therapeutics revenue & valuation
| Annual revenue | $1,711,100 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,500,000 |
| Total funding | No funding |
Key Contacts at Z-Alpha Therapeutics
Kevin Bunker
Chief Executive Officer
Michael Zalutsky
Chief Technology Officer
Fanching Lin
Director, Discovery And Translational Medicine
Guangcheng Jiang
Director Of Chemistry
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Employees | 11-20 |
Z-Alpha Therapeutics Email Formats
Z-Alpha Therapeutics uses 2 email formats. The most common is {first name} (e.g., john@duke.edu), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@duke.edu | 50% |
{first name}{last name} | johndoe@duke.edu | 50% |
About Z-Alpha Therapeutics
Z-Alpha Therapeutics is a cutting-edge radiopharmaceutical company developing novel oncology drugs for solid tumor targets
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Vice President
C-Suite
Director
Employees by Department
Z-Alpha Therapeutics has 10 employees across 8 departments.
Departments
Number of employees
Funding Data
Z-Alpha Therapeutics has never raised funding before.
Canada
France
Frequently asked questions
Z-Alpha Therapeutics is located in XX.
Z-Alpha Therapeutics generates an estimated annual revenue of $1,711,100. This revenue figure reflects the company's market position and business performance in its industry.
Z-Alpha Therapeutics has an estimated valuation of $5,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Z-Alpha Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
